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93.2% and91.5%. TheQFThad58.3% sensitivity and95.3% speciﬁcity
in diagnosing children with latent TB. The commonest discordant
results were TST+ / QFT- in 15 of 141 children without TB, not
unexpected in this BCG-vaccinated population.
Conclusion: The QFT performed better than the TST in the diag-
nosis of tuberculosis. Although only moderately sensitive, they
were highly speciﬁc in ruling out TB and showed good concordance
in TB-negative children. Although a case may be made for using
both tests in BCG-vaccinated children, the higher costs and techni-
cal expertise required for the QFT do not support its use instead of
the cheaper and simpler TST in India.
http://dx.doi.org/10.1016/j.ijid.2016.02.739
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Accuracy of the Xpert MTB/RIF assay compared
to the “gold standard” AFB culture in the
diagnosis of tuberculosis in children in India
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Background: The Xpert MTB/RIF PCR assay detects
M.tuberculosis and resistance to Rifampicin within 2-4 hours,
compared to the AFB culture that takes 4-8 weeks to provide the
same information. This study assessed the performance of the
Xpert MTB/RIF assay against the AFB culture and clinical case
deﬁnitions of intrathoracic and extrathoracic tuberculosis(TB), and
against type of specimen tested.
Methods & Materials: All children<16 years of age with sus-
pected TB seen in the Pediatric Department, Christian Medical
College, Vellore from May 2012-June 2015 and tested with Xpert
MTB/RIF assay and AFB cultures in the Department of Clinical
Microbiologywere included.Recordsand test resultswereaccessed
to classify children as conﬁrmed, probable or possible TB or TB
unlikely/not TB based on the 2014 NIH/WHO consensus and other
case deﬁnitions.
Results: 286 children with suspected TB (135 intrathoracic, 71
lymphadenitis, 51 meningitis and 28 abdominal) were reviewed.
41 of 52 children with culture-conﬁrmed TB had a positive Xpert
MTB/RIF assay (overall sensitivity 78.9%). 115 more children were
case-deﬁned TB, while 119 had no TB.
The sensitivity of the Xpert MTB/RIF assay against the AFB cul-
ture was 96% in intrathoracic TB, 78% for TB lymphadenitis, 67%
for TB abdomen and 46% for TB meningitis. The assay showed less
sensitivity against clinical case deﬁnitions, being 48% for intratho-
racic TB, 47% for TB lymphadenitis, 41% for TB abdomen and 19% for
TB meningitis. The assay diagnosed an additional 15 children with
intrathoracic TB, 11 children with TB lymphadenitis, and 3 and 2
children with TB abdomen and TB meningitis compared to the AFB
culture. Sensitivity was 100% for sputum specimens, intrathoracic
tissue and BAL samples, 90% for gastric aspirates, 78% for lymph
nodes, 67% for intra-abdominal tissue and 46% for CSF against the
AFB culture. Itwas 80% sensitive in detecting Rifampicin resistance.
The speciﬁcity of the assay in disease-negative children was 92%
for intra-thoracic and abdominal TB, 93% for TB lymphadenitis, and
100% for TB meningitis.
Conclusion: The Xpert MTB/RIF assay’s high sensitivity, speci-
ﬁcity and detection of Rifampicin resistance make it a good
point-of-care test for early diagnosis of childhood tuberculosis,
especially intrathoracic TB.
http://dx.doi.org/10.1016/j.ijid.2016.02.740
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Background: Extraintestinal pathogenic E. coli (ExPEC) cause
different infectious diseases in humans and animals, accounting
80% of urinary tract infections (UTIs), worldwide. Increase in the
prevalence of multidrug-resistant (MDR) E. coli and global dis-
semination of these clonal organisms is a signiﬁcant risk to the
public health. The present study investigates the prevalence, pop-
ulation structure, phylogenetic afﬁnities and molecular basis of
ESBL and antimicrobial resistance and also highlights the spread of
multi-drug resistant E. coli causing infections with varied clinical
spectrum
Methods&Materials: A total of 187 E. coli isolates frompatients
with different clinical complications were obtained from D.Y. Patil
Medical College, Pune, for this study. All the isolates were sub-
jected to phylogenetic grouping and speciﬁc sequence type (ST)
identiﬁcation. The ST131 strains were further evaluated for their
virulence gene proﬁles using PCR. Phenotypic and genotypic detec-
tions of antimicrobial resistance were carried out by disc diffusion
and PCR based methods, respectively. The clonality of ST131 iso-
lates with respect to strains of other sequence types was evaluated
by enterobacterial repetitive intergenic consensus PCR (ERIC-PCR).
Results: Phylogrouping of 187 E. coli isolates revealed that 78
(41.7%) isolates belonged to group A, 16 (8.6%) to group B1, 56
(29.9%) to group B2 and 37 (19.8%) to group D. Forty strains were
identiﬁed to belong to ST131. Virulence proﬁling of ST131 strains
demonstrated signiﬁcant prevalence of ﬁmH (90%), papC (82.5%),
hlyA (77.5%) traT (47.5%), sat (87.5%) and iucD (55%). The antibi-
otic resistance proﬁles of ST131 isolates showed high resistance to
ciproﬂaxin (92.5%), cotrimoxazole (67.5%) and tetracycline (62.5%).
A high proportion (60%) of these ST131 strainswasmultidrug resis-
tant and 95% were ESBL-positive. Of all the 40 ST131 strains, 42.5%
and 95% were positive for sulphonamide and streptomycin resis-
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tance encoding genes, respectively, and only 2 strains were found
to be positive for ndm-1.
Conclusion: Our study revealed that ST131 is the only predomi-
nant endemic clone present in the clinical E. coli isolates fromPune.
Molecular characterization of these isolates suggests that ST131 is
a robust lineage of pathogen that could signiﬁcantly limit medi-
cal interventions against E. coli induced enteric and extraintestinal
infections in India.
http://dx.doi.org/10.1016/j.ijid.2016.02.741
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Background: Antibiotic resistance rates vary markedly accord-
ing to geographical region. It is thus essential to have local data
on antibiotic resistance to determine the choice of antibiotics for
empirical treatment of bacterial infections. A survey was therefore
conducted to determine antibiotic resistance rates in 2014 of the
main bacterial causes of gastroenteritis and respiratory tract infec-
tions in humans, namely nontyphoidal Salmonella, Campylobacter,
Streptococcus pneumoniae and Haemophilus inﬂuenzae.
Methods & Materials: Laboratory registers at the two gov-
ernment laboratories which perform microbiological examination
were reviewed. Antibiotic susceptibility results of all nontyphoidal
Salmonella and Campylobacter from stool specimens, and pneumo-
coccusandH.inﬂuenzae fromsputum, sinusandear specimenswere
recorded. Duplicate isolates from the same patient were excluded.
Results: In 2014, 115 Salmonella isolates were recorded and
susceptibility rates to ampicillin, co-trimoxazole, nalidixic acid
and ciproﬂoxacin were 100%, 98%, 99% and 100% respectively. In
contrast only 49% of 101 Campylobacter isolates were susceptible
to ciproﬂoxacin although 96% were susceptible to erythromycin.
Among respiratory tract pathogens, only 21 of 48 (44%) of pneu-
mococcus isolates were susceptible to erythromycin and 63% had
reduced sensitivity to penicillin (Minimum inhibitory concentra-
tion [MIC]≥0.1g/mL) butnonehadhigh level penicillin resistance
(MIC>2 g/mL). 96% and 100% of pneumococci were suscepti-
ble to tetracycline and levoﬂoxacin respectively. 27 of 35 (77%)
of Haemophilus inﬂuenzae isolates were susceptible to ampicillin
and all were susceptible to cefotaxime, amoxicillin-clavulanic acid
combination and levoﬂoxacin.
Conclusion: High rates of resistance were observed for some
organism-antibiotic combinations in Mauritius in 2014 such as for
ciproﬂoxacin in Campylobacter and erythromycin in pneumococ-
cus. When compared to historical data, resistance to ciproﬂoxacin
in Campylobacter in Mauritius increased from 3.6% in 1998-2005
to 51% in 2014 and this was probbably due to antibiotic overuse
in veterinary practice. In severe bacterial gastroenteritis requir-
ing antibiotic therapy, ciproﬂoxacin is likely to be effective against
Salmonella but not against Campylobacter. Macrolide antibiotics
cannot be relied upon as monotherapy to treat infections likely to
be caused by pneumococcus in Mauritius. Control of antibiotic use
is required in bothmedical and veterinary practice tominimize the
emergence and spread of antibiotic-resistant bacteria.
http://dx.doi.org/10.1016/j.ijid.2016.02.742
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Re-emergence of susceptibility to conventional
ﬁrst line drugs in Salmonella isolates: an old
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Background: Enteric fever, caused by Salmonella is a common
clinical diagnosis among febrile patients presenting to hospital
in Nepal. The ﬁrst-line drugs ampicillin, chloramphenicol and
cotrimoxazolehavenotbeenpartof empirical therapydue todevel-
opment of multidrug-resistant Salmonella. Ciproﬂoxacin has been
theempirical therapyof choice, but the recent increase inminimum
inhibitory concentration (MIC) to ciproﬂoxacin in Salmonella enter-
ica, may result in delayed response and serious complications. The
current study investigates the re-emergence of sensitivity to con-
ventionally used drugs among strains of S. Typhi and S. Paratyphi
A in a community hospital of Kathmandu.
Methods & Materials: We evaluated 245 Salmonella isolates,
at Helping-Hands Community Hospital, Chabahil, Kathmandu, for
chloramphenicol, ampicillinandcotrimoxazole susceptibilityusing
standard methods as per the guidelines of the Clinical and Labora-
tory Standards Institute .
Results: Of the total 245 positive isolates, 50.20% (123/245)
were S. Typhi and 49.80% (122/245) were S. Paratyphi A. A total of
229 (93.5%)were Nalidixic Acid Resistant (NAR) Salmonella, includ-
ing 110(89.4%) S. Typhi and 119(97.5%) S. Paratyphi A. More than
95% of the isolates were sensitive to ampicillin, chloramphenicol,
cotrimoxazole, ceftriaxone, and ceﬁxime.
Conclusion: First generation drug were found effective indi-
cating re-emergence of susceptibility to conventional ﬁrst line
antimicrobial which may play important role in the treatment of
NAR and non MDR Salmonella isolate.
http://dx.doi.org/10.1016/j.ijid.2016.02.743
